首页> 美国卫生研究院文献>Clinical and Diagnostic Laboratory Immunology >Development and Application of Reference Antisera against 15 Hemagglutinin Subtypes of Influenza Virus by DNA Vaccination of Chickens
【2h】

Development and Application of Reference Antisera against 15 Hemagglutinin Subtypes of Influenza Virus by DNA Vaccination of Chickens

机译:鸡的DNA疫苗免疫针对15种流感病毒血凝素亚型的参考抗血清的开发和应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Reference antisera were produced against 15 influenza hemagglutinin (HA) subtypes using DNA vaccination to produce a high-quality polyclonal serum to the HA protein without antibodies to other influenza viral proteins. The HA gene from each of 15 different HA subtypes of influenza virus was cloned into a eukaryotic expression vector and injected intramuscularly, together with a cationic lipid, into 3- to 4-week-old specific-pathogen-free chickens. Birds were boostered twice at 4-week intervals after the initial injection, and in general, antibody titers increased after each boost. The antisera were successfully applied in the hemagglutination inhibition test, which is the standard method for the classification of the HA subtypes of influenza virus. We also demonstrated the HA specificity of the antisera by Western blot and immunodot blot analysis. DNA vaccination also provides a safer alternative for the production of HA-specific antibodies, since it is produced without the use of live virus.
机译:使用DNA疫苗接种产生针对15种流感血凝素(HA)亚型的参考抗血清,以产生HA蛋白的高质量多克隆血清,而没有针对其他流感病毒蛋白的抗体。将来自15种不同流感病毒亚型的每种HA基因克隆到真核表达载体中,并与阳离子脂质一起肌内注射到3至4周龄的无特定病原体的鸡中。初次注射后,鸡每隔4周加强免疫两次,通常,每次加强免疫后抗体滴度都会增加。该抗血清已成功应用于血凝抑制试验,这是对流感病毒HA亚型进行分类的标准方法。我们还通过蛋白质印迹和免疫斑点印迹分析证明了抗血清的HA特异性。 DNA疫苗接种还为生产HA特异性抗体提供了更安全的替代方法,因为它是在不使用活病毒的情况下生产的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号